[CPIX] Cumberland Pharmaceuticals Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 75.75 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 5.42 Change: 0.02 (0.28%)
Ext. hours: Change: 0 (0%)

chart CPIX

Refresh chart

Strongest Trends Summary For CPIX

CPIX is in the long-term down -18% below S&P in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the hospital acute care and gastroenterology markets in the United States. The company?s principal products comprise Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. Its products also include Omeclamox-Pak, a triple therapy combination medication for the treatment of Helicobacter pylori infection and duodenal ulcer disease; and Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome. The company markets and sells its products through sales representatives and managers. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tenne

Fundamental Ratios
Shares Outstanding16.22 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -10.9% Sales Growth - Q/Q-6.88% P/E
P/E To EPS Growth P/S2.02 P/BV0.95 Price/Cash Per Share1.43
Price/Free Cash Flow11.6 ROA2.37% ROE2.75% ROI
Current Ratio5.68 Quick Ratio5.29 Long Term Debt/Equity Debt Ratio0.15
Gross Margin86.23% Operating Margin8.41% Net Profit Margin5.82% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-1.68 M Cash From Investing Activities-1.17 M Cash From Operating Activities2.03 M Gross Profit7.52 M
Net Profit50 K Operating Profit Total Assets92.19 M Total Current Assets67.55 M
Total Current Liabilities11.89 M Total Debt Total Liabilities12.82 M Total Revenue8.69 M
Technical Data
High 52 week7 Low 52 week4.73 Last close5.53 Last change-3.49%
RSI53.94 Average true range0.39 Beta0.5 Volume2.51 K
Simple moving average 20 days-0.63% Simple moving average 50 days2.15% Simple moving average 200 days-4.66%
Performance Data
Performance Week-4.49% Performance Month11.72% Performance Quart-1.78% Performance Half-8.6%
Performance Year-0.9% Performance Year-to-date-8.29% Volatility daily3.24% Volatility weekly7.24%
Volatility monthly14.85% Volatility yearly51.42% Relative Volume74.79% Average Volume33.67 K
New High New Low

News

2020-06-15 12:00:04 | All You Need to Know About Cumberland CPIX Rating Upgrade to Buy

2020-05-27 18:00:55 | Is Cumberland Pharmaceuticals CPIX A Good Stock To Buy Now?

2020-05-26 16:05:00 | New Publication Reveals Real-World Usage of Vibativ® In Patients With Bacteremia Or Endocarditis

2020-05-22 07:30:49 | Is Cumberland Pharmaceuticals Inc. NASDAQ:CPIX Excessively Paying Its CEO?

2020-05-20 18:15:10 | Cumberland Pharmaceuticals CPIX Q1 Earnings and Revenues Miss Estimates

2020-05-20 16:05:00 | Cumberland Pharmaceuticals Reports First Quarter 2020 Financial Results & Company Update

2020-05-20 14:30:00 | Cumberland Pharmaceuticals, Inc. to Host Earnings Call

2020-05-15 16:40:00 | Cumberland Pharmaceuticals To Announce First Quarter 2020 Financial Results

2020-05-11 16:10:00 | Vibativ® Sustained Potency Confirmed In Two Surveillance Studies

2020-05-05 12:30:04 | Analysts Estimate Cumberland Pharmaceuticals CPIX to Report a Decline in Earnings: What to Look Out for

2020-04-28 09:35:00 | Cumberland Pharmaceuticals Releases Inaugural Report On Its Environmental, Social And Governance ESG Activities

2020-04-17 08:37:12 | Summit Therapeutics SMMT Catches Eye: Stock Jumps 8.9%

2020-04-16 08:37:12 | Ampio AMPE Looks Good: Stock Adds 5.2% in Session

2020-04-07 17:00:00 | To Help Prepare for the COVID-19 Patient Surge Cumberland Pharmaceuticals Expands Availability of Vaprisol® to Treat Hyponatremia in Critical Care Units

2020-04-02 13:23:05 | LLY, OXM, AMAG, MIST and CPIX as Zacks Bull and Bear of the Day

2020-03-31 17:00:00 | Cumberland Pharmaceuticals Announces Initiative to Expand Availability of Caldolor® to Help Treat High Fevers Associated With Coronavirus Infections

2020-03-23 17:00:00 | Cumberland Pharmaceuticals Announces Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections

2020-03-19 02:51:01 | Edited Transcript of CPIX earnings conference call or presentation 18-Mar-20 8:30pm GMT

2020-03-18 17:35:09 | Cumberland Pharmaceuticals CPIX Q4 Earnings and Revenues Beat Estimates

2020-03-18 16:05:00 | Cumberland Pharmaceuticals Reports 17% Revenue Growth For The Full Year 2019

2020-03-18 14:30:00 | Cumberland Pharmaceuticals, Inc. to Host Earnings Call

2020-03-17 09:35:00 | Caldolor® Demonstrates Favorable Safety Profile In Newborns

2020-03-11 12:30:04 | Earnings Preview: Cumberland Pharmaceuticals CPIX Q4 Earnings Expected to Decline

2020-03-06 16:35:00 | Cumberland Pharmaceuticals Reschedules Fourth Quarter And Annual 2019 Financial Results

2020-03-04 09:35:00 | Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2019 Financial Results

2020-01-07 16:05:00 | Cumberland Pharmaceuticals Announces The National Launch Of A New Caldolor Ready-To-Use Product

2020-01-02 09:35:00 | Cumberland Pharmaceuticals To Hold Update Call To Discuss Recent Major Developments

2019-12-22 18:43:58 | Cumberland Pharmaceuticals, Inc. CPIX: Hedge Funds In Wait-and-See Mode

2019-12-04 09:21:02 | New Strong Sell Stocks for December 4th

2019-12-02 08:00:00 | Cumberland Pharmaceuticals Receives FDA Approval for RediTrex™ Product Line

2019-11-29 18:31:09 | Edited Transcript of CPIX earnings conference call or presentation 12-Nov-19 9:30pm GMT

2019-11-25 09:35:00 | New Study Reveals Real-World Usage of Vibativ® In a Variety Of Infections

2019-11-12 16:05:00 | Cumberland Pharmaceuticals Reports 22% Revenue Growth In The Third Quarter

2019-11-05 17:45:10 | Cumberland Pharmaceuticals CPIX Dips More Than Broader Markets: What You Should Know

2019-11-05 11:24:04 | What's in Store for Cumberland Pharma CPIX in Q3 Earnings?

2019-11-05 10:32:03 | Cumberland Pharmaceuticals CPIX to Report Q3 Results: Wall Street Expects Earnings Growth

2019-11-05 09:35:00 | Cumberland Pharmaceuticals To Announce Third Quarter 2019 Financial Results

2019-11-02 10:30:11 | Is Cumberland Pharmaceuticals NASDAQ:CPIX Using Too Much Debt?

2019-10-30 17:45:09 | Cumberland Pharmaceuticals CPIX Outpaces Stock Market Gains: What You Should Know

2019-10-24 17:45:09 | Cumberland Pharmaceuticals CPIX Stock Sinks As Market Gains: What You Should Know

2019-10-16 17:50:09 | Cumberland Pharmaceuticals CPIX Dips More Than Broader Markets: What You Should Know

2019-10-15 09:35:00 | New Study Reveals Superiority Of Vibativ® Over Vancomycin In Select Patients With Bacterial Pneumonia

2019-10-10 17:45:09 | Cumberland Pharmaceuticals CPIX Outpaces Stock Market Gains: What You Should Know

2019-10-04 17:45:09 | Cumberland Pharmaceuticals CPIX Stock Sinks As Market Gains: What You Should Know

2019-09-26 11:01:03 | New Strong Buy Stocks for September 26th

2019-09-25 12:25:50 | Does Cumberland Pharmaceuticals Inc.'s NASDAQ:CPIX CEO Pay Matter?

2019-09-24 09:35:00 | Cumberland Pharmaceuticals Announces FDA Orphan Drug Grant Award For New Phase II Clinical Program

2019-09-19 08:01:12 | New Strong Buy Stocks for September 19th

2019-09-13 09:25:01 | Cumberland Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?

2019-09-12 10:26:02 | New Strong Buy Stocks for September 12th